aged, azasteroid, biopsy, blood, cancer diagnosis, cancer prevention, clinical practice, drug antagonism, dutasteride, enzyme inhibitor, human, letter, male, middle aged, note, pathology, prediction and forecasting, priority journal, prostate, prostate biopsy, prostate cancer, prostate hypertrophy, prostate specific antigen, prostate tumor, steroid 5alpha reductase
dx.doi.org/10.1056/NEJMc1005498, hdl.handle.net/1765/20966
New England Journal of Medicine
Erasmus MC: University Medical Center Rotterdam

Schröder, F.H, & Roobol-Bouts, M.J. (2010). Dutasteride and prostate cancer. New England Journal of Medicine, 363(8), 793–794. doi:10.1056/NEJMc1005498